Accretion and Accretive Value in Corporate Acquisitions
A Venture Capital Perspective
The concept of accretion and accretive value sits at the center of every M&A transaction. An acquisition is described as accretive when the acquiring company’s post-close earnings per share exceeds its standalone earnings per share prior to the deal. In the most direct sense, accretion is the test by which boards, investment bankers, and institutional shareholders determine whether a transaction benefits the acquirer’s shareholders in earnings terms.
For venture capital investors, founders, and executives engaged in M&A strategy, the accretion analysis carries particular weight. The dominant exit pathway for VC-backed companies remains M&A rather than the public markets. According to the NVCA and PitchBook Venture Monitor, total M&A exit value in 2024 reached approximately 54.5 billion dollars across 1,083 disclosed deals. The third quarter of 2025 marked the strongest exit quarter since the end of 2021, generating 75.6 billion dollars from 362 exits. Understanding whether and how a proposed acquisition is accretive shapes the terms founders are offered, the premium strategic acquirers are willing to pay, and the governance decisions boards must make under their fiduciary duties.
The landscape, however, is more complex than a single EPS metric suggests. Leading practitioners and academics, including researchers affiliated with major management consulting firms, have questioned whether EPS accretion is a reliable proxy for genuine shareholder value creation. The rise of technology acquisitions, acquihires, and AI-driven talent transactions has expanded the concept of accretive value far beyond reported earnings to encompass human capital, intellectual property, proprietary data sets, and strategic market position. This report synthesizes the mechanics of accretion analysis, situates it within the current M&A and VC exit environment, examines the accounting and regulatory frameworks that shape how accretion is measured, and identifies the open questions that founders, investors, and executives must navigate in 2026.
The Mechanics of Accretion and Dilution Analysis
An accretion and dilution analysis compares the acquirer’s pro forma combined earnings per share to its standalone earnings per share. If the combined entity’s EPS is higher than the acquirer’s standalone EPS, the deal is accretive. If combined EPS is lower, the deal is dilutive. The result depends on three primary variables: the acquisition price, the method of payment (cash, stock, or a combination), and the magnitude of expected synergies.
In an all-cash transaction, the acquirer finances the purchase through existing reserves or new debt. The interest expense associated with the debt reduces the combined entity’s net income, which in turn reduces EPS. Whether the deal is ultimately accretive depends on whether the target’s contributed earnings, net of financing costs and any transaction charges, exceed the drag introduced by the interest burden. In an all-stock transaction, the acquirer issues new shares to fund the purchase. The increase in share count dilutes the denominator of the EPS calculation. The deal is accretive on a standalone basis if the acquirer’s price-to-earnings ratio exceeds the target’s price-to-earnings ratio, assuming no synergies. Conversely, if the target trades at a higher earnings multiple than the acquirer, an all-stock deal will dilute EPS in the absence of sufficient synergies to compensate.
Synergies are the mechanism by which a dilutive deal can become accretive over time. Cost synergies arise from operational consolidation: reducing redundant headcount, consolidating facilities, rationalizing vendor contracts, and eliminating overlapping technology infrastructure. Revenue synergies arise from combining the two businesses to generate sales that neither could achieve independently, including cross-selling into each other’s customer bases, entering new geographies, and achieving greater pricing power by reducing market competition. The timeline for synergy realization is critical; a deal may be dilutive in year one and accretive by year three, and boards must evaluate whether shareholders will tolerate the near-term dilution in exchange for long-term value creation.
Purchase Price Allocation and Accounting Impact Under ASC 805
The accounting treatment of an acquisition under Accounting Standards Codification 805 (Business Combinations) materially affects whether a deal appears accretive in financial reports. Under ASC 805, the acquirer must allocate the total purchase consideration to the fair values of all identifiable assets acquired and liabilities assumed, with any residual recorded as goodwill.
The treatment of intangible assets is especially consequential for EPS accretion. Identifiable intangibles such as customer relationships, developed technology, trade names, and non-compete agreements must be separately recognized and assigned useful lives. These assets are typically amortized over their estimated useful lives, creating recurring non-cash charges that reduce reported net income and therefore reduce EPS. Goodwill, by contrast, is not amortized under current U.S. GAAP: it is tested annually for impairment. How the purchase price is allocated between amortizable intangibles and non-amortizable goodwill therefore directly determines the magnitude of the post-close earnings drag and whether the deal registers as accretive or dilutive to reported EPS.
This creates a structural tension that sophisticated acquirers navigate carefully. Allocating more of the purchase price to goodwill and indefinite-lived intangibles reduces ongoing amortization charges and improves the short-term accretion profile. However, it also concentrates acquisition risk in the goodwill balance, which becomes subject to impairment testing. A large goodwill balance that is later impaired forces a non-cash write-down through the income statement, which can be significantly dilutive in the period of impairment. The allocation decision is therefore both an accounting judgment and a strategic risk management choice.
The Challenge of EPS Accretion as a Value Creation Metric
Accretion and dilution analysis has long been a centerpiece of M&A decision-making, but leading practitioners have raised serious questions about whether EPS accretion reliably signals genuine shareholder value creation. Research published by major management consulting institutions has concluded that there is no meaningful correlation between whether a deal is accretive or dilutive in the first year and the market’s long-term assessment of the transaction’s value.
The critique rests on several structural arguments. First, EPS accretion can be achieved through financial engineering rather than operational improvement. An acquirer with a high price-to-earnings multiple can purchase a lower-multiple target and produce EPS accretion through the P/E differential alone, regardless of whether the combined business is genuinely more valuable. Second, EPS accretion ignores the economic cost of capital. A deal that is accretive to reported earnings but destroys economic value (because the premium paid exceeds the present value of synergies) is being labeled a success by the wrong metric. Third, the accounting treatment of goodwill and intangibles under revised standards has made nearly every acquisition appear accretive before restructuring charges, further eroding the metric’s informational value.
The preferred alternative measure, endorsed by leading academic and practitioner research, is an evaluation of whether the synergy value generated by the transaction exceeds the acquisition premium paid. This framework, grounded in discounted cash flow analysis, requires the acquirer to construct a rigorous standalone valuation of the target, estimate synergies with credible timelines and probability weightings, and compare the total anticipated value creation against the premium paid above the target’s standalone value. Transactions that pass this test create genuine shareholder value even if they are temporarily dilutive to reported EPS.
Accretive Value in the VC-Backed M&A Exit Context
The concept of accretive value takes on distinct dimensions in the venture capital ecosystem. For VC investors, the relevant question is not only whether a transaction is accretive to the acquirer’s EPS but whether the acquisition price delivers returns that justify the risk and time horizon of the venture investment. Only approximately 7 percent of VC-backed M&A exits return at least three times the total venture capital raised, according to published Crunchbase analysis. This data point underscores the competitive dynamics of strategic M&A pricing and the importance of understanding what drives acquirers to pay premium prices.
Strategic acquirers pay accretive premiums when the target’s contribution to the combined entity generates earnings, capabilities, or market position that the acquirer cannot replicate organically at comparable cost or speed. For technology companies, this calculation frequently centers on product and technology accretion: the value of an acquired product line, software platform, or data asset relative to the internal cost of building equivalent capabilities. The “build versus buy” calculus has intensified in the artificial intelligence era, where talent scarcity and rapid model development cycles make internal development an uncertain and time-consuming alternative to acquisition.
The acquihire transaction structure captures the most extreme form of talent-driven accretive value. In an acquihire, the acquirer is paying primarily for the target’s team rather than its revenue, customers, or technology assets. The transaction may be structured as an asset purchase with substantial retention packages for key personnel. Leading technology acquisitions in 2025 illustrate the scale of talent premiums: Google paid approximately 2.4 billion dollars to acquire key personnel from an AI coding startup; an earlier technology firm acquisition reached 650 million dollars for a team of AI researchers. In each case, the traditional EPS accretion framework is largely inapplicable because the acquired business has minimal earnings to contribute. The accretive value is human capital: the expected output of the acquired team applied to the acquirer’s platform and resources.
The 2025 to 2026 M&A Market Environment
The broader M&A market has provided a supportive backdrop for accretive acquisition strategies. Global M&A deal value increased approximately 43 percent between 2024 and 2025, representing the strongest 12-month period since 2021. Corporate-to-corporate dealmaking dominated activity, with technology, infrastructure, and energy sectors driving the largest transactions. The Lazard 2025 M&A Review and 2026 Outlook report identified scale and strategic positioning as the primary drivers of significant transactions in 2025, with corporates expected to continue shaping market activity through 2026.
For VC-backed companies, the reopening of M&A exit channels has provided meaningful liquidity after a constrained period. The number of active public company acquirers declined substantially from 2021 peaks, falling from approximately 1,423 to 815 between 2021 and 2024, reflecting higher borrowing costs and compressed valuation multiples. Nonetheless, AI-sector M&A activity generated over 10 billion dollars across 365 deals in the first half of 2025, signaling that strategic acquirers remain highly active in capability-building transactions even under tighter capital conditions.
The declining pool of active acquirers also concentrates pricing power among well-capitalized strategic buyers. For founders and VC investors seeking premium exits, this dynamic reinforces the importance of positioning VC-backed companies as genuinely accretive acquisition targets: capable of delivering above-market EPS contribution, synergistic revenue opportunities, or differentiated capabilities that justify a premium above comparable market transactions.
Governance Considerations and Board Fiduciary Duties
For boards of both acquirers and targets, the accretion analysis intersects directly with fiduciary duties. Acquirer boards must evaluate whether the proposed transaction creates or destroys shareholder value, which requires engaging seriously with the limitations of EPS accretion as a sole measure and supplementing it with DCF-based valuation analysis and rigorous synergy modeling. Accepting a deal that is accretive in the short term but strategically unsound or overpaid relative to standalone value exposes directors to scrutiny.
Target company boards, particularly those of VC-backed companies approaching an exit, have their own fiduciary obligations under applicable state corporate law. In states that follow enhanced scrutiny standards in the M&A context, boards must demonstrate that the process used to evaluate the acquisition was reasonable and that the resulting price falls within a range of fairness. A sophisticated understanding of accretion mechanics enables target boards to assess whether an acquirer’s bid reflects full recognition of the synergies the target brings to the combined entity, or whether the acquirer is capturing accretive value at the target’s shareholders’ expense.
Open Questions
1. Will the expansion of acquihire and license-and-hire transaction structures require new accounting frameworks or regulatory guidance under ASC 805 and related standards to accurately capture the fair value of acquired human capital and AI model assets? Current GAAP treatment of internally developed AI and workforce value does not adequately reflect economic reality, leaving significant value off-balance sheet.
2. As AI-driven tools enable more precise modeling of synergy realization and transaction risk, will boards and investment banks accelerate the shift away from EPS accretion as the primary merger evaluation metric toward economic profit and DCF-based standards? If so, what governance and disclosure standards should accompany that transition?
3. How will the concentration of M&A activity among a smaller pool of well-capitalized strategic buyers affect the premium pricing available to VC-backed exit candidates, particularly at growth-stage companies in sectors where acquirer competition has diminished?
4. To what extent do VC investors’ liquidation preference structures and anti-dilution provisions affect the net proceeds delivered to founders and common shareholders in accretive acquisition scenarios, particularly where acquisition prices fall below peak private valuations?
5. As regulators in the United States and internationally increase scrutiny of large technology acquisitions on competitive grounds, how does antitrust risk affect the accretion calculus for deals involving AI platforms, data assets, and dominant market positions?
Source List
1. NVCA and PitchBook, Venture Monitor Q4 2025: Primary benchmark for U.S. VC M&A exit volume and value data cited throughout this report. https://nvca.org/wp-content/uploads/2026/01/q4-2025-pitchbook-nvca-venture-monitor.pdf
2. NVCA and PitchBook, Venture Monitor Q3 2025: Provides exit market data including total exit value and deal counts for Q3 2025. https://nvca.org/wp-content/uploads/2025/10/Q3-2025-PitchBook-NVCA-Venture-Monitor.pdf
3. Lazard, 2025 M&A Review and 2026 Outlook (January 2026): Macroeconomic M&A market analysis including deal value growth statistics and strategic deal drivers. https://www.lazard.com/media/vnajb4v3/2025-ma-review-and-2026-outlook-report.pdf
4. McKinsey and Company, Merger Valuation: Time to Jettison EPS: Foundational critique of EPS accretion as a merger valuation metric and recommendation of economic profit analysis. https://www.mckinsey.com/capabilities/strategy-and-corporate-finance/our-insights/merger-valuation-time-to-jettison-eps
5. Harvard Business School, Do Appearances Matter? The Impact of EPS Accretion and Dilution on Stock Prices: Academic analysis of EPS accretion and its relationship to market price responses. https://www.hbs.edu/ris/Publication%20Files/00-007_d2f48676-86f0-4450-903f-9116c4d8e75c.pdf
6. BDO, Understanding ASC 805: What PE Firms and CFOs Need to Know Ahead of Transactions: Practitioner guidance on purchase price allocation mechanics and their implications for post-close earnings. https://www.bdo.com/insights/assurance/understanding-asc-805-what-pe-firms-and-cfos-need-to-know-ahead-of-transactions
7. Corporate Finance Institute, Accretion Dilution Analysis: Technical reference on the mechanics of accretion and dilution modeling. https://corporatefinanceinstitute.com/resources/valuation/accretion-dilution/
8. Crunchbase News, Bigger Outcomes as Startup Exits Gain Steam in 2025: Market data on VC-backed M&A exit premiums and return multiples. https://news.crunchbase.com/venture/startup-billion-dollar-exits-growing-ma-ipo-august-2025/
9. SG Analytics, U.S. VC-Backed M&A in 2025: Deals and Exits: Analysis of VC-backed M&A activity including deal count and acquirer dynamics. https://www.sganalytics.com/blog/us-vs-backed-ma-deals-and-exits/
10. Founders Forum Group, AI Acquihires: How Microsoft, Google, and Meta Acquire for Hire in the Talent Wars: Analysis of high-profile acquihire transactions and their economic rationale. https://ff.co/ai-acquihires/
11. Surfside Capital Advisors, Accretive vs. Dilutive Mergers: Understanding the Impact on Shareholder Value (October 2024): Practitioner analysis of accretion and dilution dynamics in current market. https://www.surfcapadvisors.com/2024/10/10/accretive-vs-dilutive-mergers-understanding-the-impact-on-shareholder-value/
12. Slaughter and May, M&A Outlook for 2026: Forward-looking analysis of global M&A market conditions and strategic transaction drivers. https://www.slaughterandmay.com/horizon-scanning/2026/capital-flows/m-a-outlook-for-2026/
Bibliography
BDO. “Understanding ASC 805: What PE Firms and CFOs Need to Know Ahead of Transactions.” BDO USA, 2025. https://www.bdo.com/insights/assurance/understanding-asc-805-what-pe-firms-and-cfos-need-to-know-ahead-of-transactions.
Corporate Finance Institute. “Accretion Dilution Analysis: Definition and Effect on Mergers.” Corporate Finance Institute, 2025. https://corporatefinanceinstitute.com/resources/valuation/accretion-dilution/.
Crunchbase News. “Bigger Outcomes as Startup Exits Gain Steam in 2025.” Crunchbase, August 2025. https://news.crunchbase.com/venture/startup-billion-dollar-exits-growing-ma-ipo-august-2025/.
Founders Forum Group. “AI Acquihires: How Microsoft, Google, and Meta Acquire for Hire in the Talent Wars.” Founders Forum Group, 2025. https://ff.co/ai-acquihires/.
Harvard Business School. “Do Appearances Matter? The Impact of EPS Accretion and Dilution on Stock Prices.” Harvard Business School Working Paper No. 00-007. https://www.hbs.edu/ris/Publication%20Files/00-007_d2f48676-86f0-4450-903f-9116c4d8e75c.pdf.
Lazard. “2025 M&A Review and 2026 Outlook.” Lazard, January 8, 2026. https://www.lazard.com/media/vnajb4v3/2025-ma-review-and-2026-outlook-report.pdf.
McKinsey and Company. “Merger Valuation: Time to Jettison EPS.” McKinsey Quarterly. https://www.mckinsey.com/capabilities/strategy-and-corporate-finance/our-insights/merger-valuation-time-to-jettison-eps.
National Venture Capital Association and PitchBook. “Q3 2025 PitchBook-NVCA Venture Monitor.” NVCA, October 2025. https://nvca.org/wp-content/uploads/2025/10/Q3-2025-PitchBook-NVCA-Venture-Monitor.pdf.
National Venture Capital Association and PitchBook. “Q4 2025 PitchBook-NVCA Venture Monitor.” NVCA, January 2026. https://nvca.org/wp-content/uploads/2026/01/q4-2025-pitchbook-nvca-venture-monitor.pdf.
SG Analytics. “U.S. VC-Backed M&A in 2025: Deals and Exits.” SG Analytics, 2025. https://www.sganalytics.com/blog/us-vs-backed-ma-deals-and-exits/.
Slaughter and May. “M&A Outlook for 2026.” Horizon Scanning, 2026. https://www.slaughterandmay.com/horizon-scanning/2026/capital-flows/m-a-outlook-for-2026/.
Surfside Capital Advisors. “Accretive vs. Dilutive Mergers: Understanding the Impact on Shareholder Value.” Surfside Capital Advisors, October 2024. https://www.surfcapadvisors.com/2024/10/10/accretive-vs-dilutive-mergers-understanding-the-impact-on-shareholder-value/.
Interested in analysis about the intersection of tech, policy and the law? Check out my Substack channel. https://theinnovationattorney.substack.com/p/accretive-value-in-m-and-a-transactions